Literature DB >> 9668222

Molecular and antigenic structure of nicotinic acetylcholine receptors.

J Lindstrom1, X Peng, A Kuryatov, E Lee, R Anand, V Gerzanich, F Wang, G Wells, M Nelson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668222     DOI： 10.1111/j.1749-6632.1998.tb10910.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  7 in total

1.  Specific immunotherapy of experimental myasthenia gravis by a novel mechanism.

Authors:  Jie Luo; Alexander Kuryatov; Jon M Lindstrom
Journal:  Ann Neurol       Date:  2010-04       Impact factor: 10.422

2.  Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice.

Authors:  Katsuyoshi Ishii; Jamie K Wong; Katumi Sumikawa
Journal:  J Comp Neurol       Date:  2005-12-12       Impact factor: 3.215

3.  Myasthenia gravis and the tops and bottoms of AChRs: antigenic structure of the MIR and specific immunosuppression of EAMG using AChR cytoplasmic domains.

Authors:  Jon Lindstrom; Jie Luo; Alexander Kuryatov
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

4.  Acetylcholine-stimulated [3H]GABA release from mouse brain synaptosomes is modulated by alpha4beta2 and alpha4alpha5beta2 nicotinic receptor subtypes.

Authors:  Tristan D McClure-Begley; Nathan M King; Allan C Collins; Jerry A Stitzel; Jeanne M Wehner; Christopher M Butt
Journal:  Mol Pharmacol       Date:  2009-01-12       Impact factor: 4.436

Review 5.  Structural answers and persistent questions about how nicotinic receptors work.

Authors:  Gregg B Wells
Journal:  Front Biosci       Date:  2008-05-01

6.  A Novel Approach to Reinstating Tolerance in Experimental Autoimmune Myasthenia Gravis Using a Targeted Fusion Protein, mCTA1-T146.

Authors:  Alessandra Consonni; Sapna Sharma; Karin Schön; Cristina Lebrero-Fernández; Elena Rinaldi; Nils Yngve Lycke; Fulvio Baggi
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 7.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.